Nanoviricides (NNVC) Selling, General & Administrative (2010 - 2026)
Nanoviricides (NNVC) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.13 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 216.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 593.21 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 347.92 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -196.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 247.47 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 161.89 Mn |
| 10 | Nanoviricides | 28.74 Mn | 25.53 Mn | - | 744,276.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 744,276.00 |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 803,619.00 |
| Jun 30, 2025 | 938,195.00 |
| Mar 31, 2025 | 966,905.00 |
| Dec 31, 2024 | 902,700.00 |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 693,742.00 |
| Dec 31, 2023 | 610,877.00 |
| Sep 30, 2023 | 564,926.00 |
| Jun 30, 2023 | 763,422.00 |
| Mar 31, 2023 | 614,647.00 |
| Dec 31, 2022 | 663,284.00 |
| Sep 30, 2022 | 509,701.00 |
| Jun 30, 2022 | 621,223.00 |
| Mar 31, 2022 | 532,801.00 |
| Dec 31, 2021 | 659,268.00 |
| Sep 30, 2021 | 515,445.00 |
| Jun 30, 2021 | 490,173.00 |